ZDHHC4 and neoplastic disease or syndrome: It is conceivable that different chemotherapy/growth factor combinations and doses and/or intrinsic characteristics of the underlying neoplastic disorder account for differences in the relative proportion of DC1/DC2 precursors and in their mobilization kinetics.